Yale formula (update of the Roach formula). - Evidencio
Yale formula (update of the Roach formula).
A new formula for prostate cancer lymph node risk
Many investigators have created tools for predicting extraprostatic disease and lymph node (LN) involvement. One widely used tool is a linear formula created by Roach et al. the Roach formula (RF), which defines the risk of pelvic LN as follows: (% pelvic LN risk = prostate-specific antigen [PSA])2/3 + (Gleason – 6))10). There has been significant stage migration in prostate cancer over the past decade since the creation of the RF. To provide clinicians with a practical approach to estimating LN risk that was developed from a population-based sample of patients who reflect the vast majority of patients diagnosed in the modern PSA era, and whose care reflects current patterns of care, we developed and validated a new predictive formula using the SEER database. A fast, accurate, and easy-to-use formula would be helpful in discussing LN risk with patients and in the conceptualization of LN risk for future clinical trials.
Forschungsautoren: James B. Yu, Danil V. Makarov, Cary Gross
Version: 1.10
  • Öffentlich
  • Onkologie
  • {{ modelType }}
  • Algorithmus
  • Details
  • Validieren Sie
  • Eingabe speichern
  • Eingabe laden
  • {{ toolbarErrorMessage }}

Anzeige
Einheiten

{{ section.title }}

{{ section.description }}

Berechnen Sie das Ergebnis

Legen Sie weitere Parameter zur Durchführung der Berechnung fest

The calculated probability of lymph node involvement is: %

{{ resultSubheader }}
{{ $t('download_result_availability') }}
slide-left-right {{ $t('scroll_chart') }}
{{ chart.title }}
Ergebnisintervall {{ additionalResult.min }} bis {{ additionalResult.max }}

Bedingte Informationen

Ihre Texteingabe(n) wurde(n) geändert. Aktualisieren Sie Ihr Ergebnis. Aktualisieren

Reported sensitivity is 39% and specificity is 94,9%.
Compared to the Roach Formula (RF) and Nguyen Formula (NF), our Yale Formula (YF) was able to classify the most patients in the high-risk (>15%) group while still maintaining good PPV and specificity. The YF had the best combination of sensitivity with high specificity and did not underestimate LN risk as the NF did. Underestimation of LN risk is potentially more harmful than overestimation of risk if patients are counseled to undergo prostate-only therapy based on an underestimation of risk, whereas they could potentially undergo pelvic LN irradiation with a chance at improving subsequent pelvic and cure rates. The utility of pelvic radiotherapy remains controversial, but it stands to reason that pelvic radiotherapy should be given more often to patients at higher risk for LN metastases than to those who are at lower risk.

{{ file.classification }}
PRO
Anmerkung
Notizen sind nur im Ergebnis-Download sichtbar und werden von Evidencio nicht gespeichert.

Dieses Algorithmus wird zu Bildungs-, Schulungs- und Informationszwecken bereitgestellt. Es darf nicht zur Unterstützung der medizinischen Entscheidungsfindung oder zur Erbringung medizinischer oder diagnostischer Leistungen verwendet werden. Lesen Sie unseren vollständigen disclaimer.

Zugrunde liegende Algorithmen Teil von
Kommentare
Kommentar
Bitte geben Sie einen Kommentar
Kommentare sind für jeden sichtbar.

Algorithmus-Feedback

Noch keine Rückmeldung 1 Kommentar {{ model.comments.length }} Kommentare
An {{ comment.created_at }} {{ comment.user.username }} ein nicht mehr registrierter Autor schrieb:
{{ comment.content }}
logo

Bitte melden Sie sich an, um die Evidencio-Druckfunktionen zu aktivieren

Um die Evidencio-Druckfunktionen nutzen zu können, müssen Sie angemeldet sein.
Wenn Sie keinen Evidencio-Community-Account besitzen, können Sie sich kostenlos ein persönliches Konto erstellen:

https: // www. evidencio.com/registration

Gedruckte Ergebnisse - Beispiele 2026-08-05 12:10


Vorteile des Evidencio-Community-Kontos


With an Evidencio Community account you can:

  • Create and publish your own prediction algorithms.
  • Share your prediction algorithms with your colleagues, research group, organization or the world.
  • Review and provide feedback on algorithms that have been shared with you.
  • Validate your algorithms and validate algorithms from other users.
  • Find algorithms based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction algorithms and their data.
  • Use patient specific protocols and guidelines based on sequential algorithms and decision trees.
  • Stay up-to-date with new algorithms in your field as they are published.
  • Create your own lists of favorite algorithms and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.


Disclaimer: Berechnungen allein sollten niemals die Pflege der Patienten vorschreiben und ersetzen kein professionelles Urteilsvermögen.